Black Bird Biotech, Inc.
Black Bird Biotech, Inc.
Your view on BBBT
Overview
What the company does, where it operates, and who runs it.
About Black Bird Biotech, Inc.
- Industry
- Drug Manufacturers - Specialty & Generic
- Sector
- Healthcare
- CEO
- Nelson Grist
- Headquarters
- 3505 Yucca Drive, Argyle, TX, US
- Industry
- Drug Manufacturers - Specialty & Generic
- Sector
- Healthcare
- CEO
- Nelson Grist
- Headquarters
- 3505 Yucca Drive, Argyle, TX, US
Black Bird Biotech Inc. provides various biotech products. It manufactures and distributes MiteXstream, a plant-based biopesticide for the eradication of spider mites.
The company also manufactures and sells CBD Oils, gummies and pet treats, CBD-infused personal care products, and hand sanitizer gel and spray products under the Grizzly Creek Naturals brand name. In addition, it grows industrial hemp under the Montana Hemp pilot program.
The company was formerly known as Digital Development Partners, Inc. and changed its name to Black Bird Biotech, Inc. in June 2021. Black Bird Biotech, Inc. is based in Flower Mound, Texas.
Media
Infographics, videos, and posts covering the company.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks it is worth vs. the current price.
FRC's fair value estimate for Black Bird Biotech, Inc., and the rating behind it. BBBT last traded at $0.0001; the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Valuation, profitability, liquidity and leverage ratios for Black Bird Biotech, Inc.. Starting points for Black Bird Biotech, Inc.: EPS -$0.0050, beta 2.00 — an Drug Manufacturers - Specialty & Generic name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Dividend history, yield and payout sustainability for Black Bird Biotech, Inc.. Black Bird Biotech, Inc. does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Reported vs. expected earnings history for Black Bird Biotech, Inc.. Trailing twelve-month EPS for Black Bird Biotech, Inc. stands at -$0.0050. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Income statement, balance sheet and cash flow history for Black Bird Biotech, Inc.. Black Bird Biotech, Inc. has reported as a listed company since 2009. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
Black Bird Biotech, Inc. valued side by side against its closest peers. Black Bird Biotech, Inc. is measured against Drug Manufacturers - Specialty & Generic peers within the Healthcare sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.
Institutional Ownership
PremiumWhich funds and firms own the stock.
Which institutions hold Black Bird Biotech, Inc., and how their positions are changing. At a $98,405 market value, institutional positions materially move Black Bird Biotech, Inc.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings. Included with FRC Premium.
Insider Trading
PremiumRecent buying and selling by company executives.
Buying and selling by Black Bird Biotech, Inc. executives and directors. Shares of Black Bird Biotech, Inc. have traded between $0.0001 and $0.0001 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned. Included with FRC Premium.
Senate Trading
PremiumU.S. Senator disclosures filed under the STOCK Act.
U.S. Senate disclosures naming Black Bird Biotech, Inc.. Black Bird Biotech, Inc. is a $98,405 Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely. Included with FRC Premium.
House Trading
PremiumU.S. Representative disclosures filed under the STOCK Act.
U.S. House of Representatives disclosures naming Black Bird Biotech, Inc.. Representatives' reported transactions in this security, shown next to the company's fundamentals. Included with FRC Premium.
News
Latest headlines and market coverage.
Latest headlines and company announcements for Black Bird Biotech, Inc.. Coverage tracks Black Bird Biotech, Inc. within Drug Manufacturers - Specialty & Generic (Healthcare). Press releases and market coverage, newest first.